1-6 of 6
Yumiko Yoshiki
Close
Sort by
Journal Articles

Retrospective Analysis of the Efficacy and Safety of Modified Bortezomib-Lenalidomide-Dexamethasonelite (modified RVD-lite) Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Kiyoshi Okazuka, MD, Tadao Ishida, MDPhD, Junichiro Nashimoto, MD, Takao Yogo, MD, Kanji Miyazaki, MD, Kota Sato, MDPhD, Yui Uto, MD PhD, Mizuki Ogura, MDPhD, Yumiko Yoshiki, MDPhD, Yu ABE, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1961.
https://doi.org/10.1182/blood-2018-99-112294
Published: 2018
Journal Articles

Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases

Kiyoshi Okazuka, MD, Nobuhiro Tsukada, Kota Sato, MD, Kanji Miyazaki, Yumiko Yoshiki, Yu Abe, MD, Tadao Ishida, MD, Kenshi Suzuki
Journal: Blood
Blood (2017) 130 (Supplement 1): 4542.
https://doi.org/10.1182/blood.V130.Suppl_1.4542.4542
Published: 2017
Journal Articles

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

Kenshi Suzuki, Miho Kasuga, trainee, Kanji Miyazaki, MD, Sohsuke Meshitsuka, MD, Yu ABE, MD, Yumiko Yoshiki, MD PhD, Nobuhiro Tsukada, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4224.
https://doi.org/10.1182/blood.V126.23.4224.4224
Published: 2015
Journal Articles

A Randomized Controlled Study Evaluating The Efficacy Of Aprepitant For Highly Emetogenic Chemotherapies In Hematological Malignancies

Ryo Nasu, Dr, Yasuhito Nannya, MD, PhD, Akihide Yoshimi, MD, PhD, Masataka Hosoi, M.D., Ph.D., Kouki Ueda, MD, PhD, Yumiko Yoshiki, MD, PhD, Shunya Arai, MD, PhD, Akihito Shinohara, M.D., Ph.D., Fumihiko Nakamura, MD, PhD, Mineo Kurokawa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1790.
https://doi.org/10.1182/blood.V122.21.1790.1790
Published: 2013
Journal Articles

Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65–70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network

Shuji Ozaki, MD, PhD, Takeshi Harada, MD, Takayuki Saitoh, M.D. Ph.D., Chihiro Shimazaki, MD, PhD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Yoshiaki Kuroda, MD, PhD, Takaaki Chou, MD, PhD, Yumiko Yoshiki, MD, Kenshi Suzuki, MD, PhD, Hirokazu Murakami, M.D., Ph.D., Kunihiko Hayashi, PhD, Antonio Palumbo, MD, Kazuyuki Shimizu, MD
Journal: Blood
Blood (2012) 120 (21): 5030.
https://doi.org/10.1182/blood.V120.21.5030.5030
Published: 2012
Journal Articles

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins

Akihide Yoshimi, Susumu Goyama, Naoko Watanabe-Okochi, Yumiko Yoshiki, Yasuhito Nannya, Eriko Nitta, Shunya Arai, Tomohiko Sato, Munetake Shimabe, Masahiro Nakagawa, Yoichi Imai, Toshio Kitamura, Mineo Kurokawa
Journal: Blood
Blood (2011) 117 (13): 3617–3628.
https://doi.org/10.1182/blood-2009-12-261602
Published: 2011
Includes: Supplemental data